Mary M. Knapp

A Public Health Economic Assessment of Hospitals' Cost to Screen Newborns for Critical Congenital Heart Disease

S. Grosse, Cora Peterson, K. V. N. Braun, 2014, Public health reports.

Results From the New Jersey Statewide Critical Congenital Heart Defects Screening Program

A. Kemper, K. Van Naarden Braun, R. Olney, 2013, Pediatrics.

Rapid Implementation of Pulse Oximetry Newborn Screening to Detect Critical Congenital Heart Defects — New Jersey, 2011

Cora Peterson, K. Van Naarden Braun, R. Olney, 2013, MMWR. Morbidity and mortality weekly report.

Neural Tube Defects in Pregnancies Among Women With Diagnosed HIV Infection — 15 Jurisdictions, 2013–2017

M. Lampe, Nina E Forestieri, J. Reefhuis, 2020, MMWR. Morbidity and mortality weekly report.

Population-Based Surveillance for Birth Defects Potentially Related to Zika Virus Infection - 22 States and Territories, January 2016-June 2017.

C. Moore, Nina E Forestieri, S. Gilboa, 2020, MMWR. Morbidity and mortality weekly report.

Isotretinoin Embryopathy—A Continuing Problem

E. Rappaport, Mary M. Knapp, 1989, Journal of clinical pharmacology.

Rapid Implementation of Pulse Oximetry Newborn Screening to Detect Critical Congenital Heart Defects — New Jersey, 2011

Cora Peterson, K. Van Naarden Braun, R. Olney, 2013, MMWR. Morbidity and mortality weekly report.